Sixty cases of colonic carcinoma have been investigated for antitumour immunoreactivity. The tests employed were blood lymphocyte reactivity and complementdependent serum cytotoxicity against cultured tumour cells, and immunofluorescence for membrane staining of viable tumour cells and cytoplasmic staining of dried tumour cells in films. Nineteen cases were positive by one or more tests and the most frequent positive response, lymphocytotoxicity, was detected in 8 of the 24 cases tested in this way. The lymphocytotoxicity persisted in a case tested three times over a year. Immunoreactivity against tumour cell surface, as by lymphocyte or serum cytotoxicity or membrane immunofluorescence, was restricted to colonic carcinomas but there was an additional element ofindividual specificity; cross-reactivity with other tissues and tumours was not observed. Lymphocytes from regional lymph nodes were non-reactive even in a case with positive blood lymphocyte cytotoxicity against the carcinoma cells.
Introduction
Colonic carcinoma has been a favoured target of immunologists for a decade. Interest in deletion of intestine-specific antigens from the carcinomas (Nairn et al., 1962) was followed by the detection of re-emergent embryonic antigens in them (Gold and Freedman, 1965) , of circulating antibodies to these antigens (Gold, 1967) , and of cellular immunity, possibly against similar targets (Hellstr6m et al., 1970) . So far there has not been a general survey of antitumour reactivity by diverse tests in a large series of patients. In the present investigation of 60 cases of colonic carcinoma antitumour activity by patients' sera and peripheral blood lymphocytes was studied by the same immunofluorescence and cultural serum and lymphocyte cytotoxicity tests as for human skin carcinoma (Nairn et al., 1971) . Immunoreactivity by one or more of the tests was found in more than 30% of all patients investigated and in more than 500/ of those examined by every test.
Methods
The following procedures were virtually identical with those already described for skin carcinomas (Nairn et al., 1971) : tumour and blood sample collection; preparation of tumour cell and lymphocyte suspensions; culture and any freezestorage of cells; and tests on tumour cells for lymphocytotoxicity, complement-dependent serum cytotoxicity in culture, and, by immunofluorescence, for membrane-reactive and cyto-plasm-reactive serum antibodies. The only differences were that special attention was paid to (a) removing mucus from the original tumour cell suspension by additional washing in medium 199 and filtering through layers of cotton gauze, and (b) avoiding overgrowth of microbial contaminants in culture by adding extra antibiotics. Benzylpenici]lin (500 IU/ml), ampicillin (125 ,ug/ml), streptomycin sulphate (125 ,ug/ml), and nystatin (100 IU/ml) were used routinely. Despite the abundance of micro-organisms in the original tumour cell suspensions the initial washing and the antibiotic mixture permitted successful growth in more than three-quarters of the cultures, apparently uninfluenced by contamination. Nevertheless, the tests on the cell suspensions were more frequently troublesome than with non-mucinous, less-contaminated tumours. Special care was required in immunofluorescence tests in the correct interpretation of any stained mucinous debris or microorganisms either free or attached to tumour cells. Triplicating cytotoxicity tests was particularly important because sporadic cultures throughout a test series become useless from overgrowth of micro-organisms.
The cell suspensions in general contained not less than 8000 tumour cells with dye exclusion viability from 1 to 9000, most commonly around 1500. Though the dye exclusion test usually gave a fair indication of the potential for tumour cell growth in culture it often did not correlate well at low values, and tumours even with 10% viability sometimes grew adequately for satisfactory cytotoxicity tests. The tumour cells were readily identified from their columnar shape and granular cytoplasm (Special Plate, Fig. 1 ).
In the absence of serum cytotoxicity or lymphocytotoxicity carcinoma cells usually grew well on the coverglass of the culture chambers (Special Plate, Fig. 2 ), free of dead cells and debris, which fell away from the upper viable monolayer. It should be recalled that it is the formation of this monolayer of readily identifiable tumour cells which indicates absence of cytotoxicity. Any cytotoxic effect will be exerted either from the outset on tumour cells in suspension, preventing their attachment to glass, or subsequently on some which initially succeed in growing on glass. When these are damaged by serum or lymphocyte toxicity they round up, show other evidence of degeneration, and fall away from the coverglass. A positive response is thus indicated by the presence of very few, mainly degenerate carcinoma cells on the coverglass by the fifth day of culture, as opposed to proliferation of a monolayer of carcinoma cells in parallel control experiments.
In lymphocytotoxic reactions tumour cells have one or more lymphocytes firmly attached to them (Special Plate, Fig. 3 ) that cannot be dislodged, as in the case of cells in casual contact, by tapping the coverglass during microscopical observation. The ratio of added lymphocytes to tumour cells whether viable or non-viable has been about 2-5:1 at the start of culture. The non-viable cells might well have surface antigenic deficiency, so that the lymphocyte to viable tumour cell ratio could be the important criterion to consider. This, however, can only be numerically assessed when the culture is first set up in terms of some arbitrary cell viability test, which may not infrequently fail to reflect tumour growth potential. All that can be said is that the number of added lymphocytes per viable tumour cell varied from culture to culture between the extremes of about 3 and 250. Our experimental data have not revealed that variability in this proportion or in tumour growth potential has influenced actual lymphocytotoxicity results.
Time-lapse cinephotomicrography was employed to examine in detail one positive lymphocytotoxicity culture, as already described for squamous cell carcinoma. The lymphocytes were added to a five-day tumour culture giving a final ratio of 10 to 1 tumour cell while at the same time replacing the original with fresh medium. Cine-film was obtained of initial lymphocyte contact and attachment to a tumour cell.
In four cases lymphocytes for toxicity testing against the tumour cells were obtained from regional lymph nodes received with the carcinoma specimens.
By membrane immunofluorescence positive viable cells in suspension showed the characteristic speckled surface staining and also occasional aggregation at one pole of the cell, possibly reflecting concentration of antigenic material at the luminal border (Special Plate, Figs. 4 and 5) . Cytoplasmic immunofluorescence on dried cell films sometimes showed polar or bipolar distribution of staining (Special Plate, Fig. 6 ). By either immunofluorescence test extreme care and "blind" recording by an experienced fluorescence microscopist have been essential to obtain consistently reliable results. In negative control tests there should be virtually no staining of intact tumour cells, and in positive tests the majority of identifiable tumour cells should be unequivocally stained. Minor populations of non-tumour cells, fragments, mucous debris, and microorganisms may stain nonspecifically in both test and control preparations; they must be distinguished morphologically and ignored in assessment of the antitumour reactivity.
IMMUNOLOGICAL SPECIFICITY
Tests of specificity were the same as in the squamous cell carcinoma study but on a much larger series of cases. Lymphocyte and serum reactivity were tested against normal colonic mucosal cells from the same or other patients and against different carcinomas of the colon and of other organs. In addition the serum cytotoxicity tests were done with added human blood group AB serum complement before and after inactivation. Serum absorptions for serum cytotoxicity and immunofluorescence studies of the colonic carcinomas were made with autologous and homologous carcinomas of the colon and normal colon and homologous normal liver.
Monospecific antihuman-globulin conjugates were used to examine the immunoglobulin class responsible for any positive immunofluorescent staining. All positive sera were also examined by immunofluorescence for possible autoantibodies against normal colon mucosa, nuclei, mitochondria, smooth muscle, and other normal tissue elements. Antimitochondrial activity may give misleading cytoplasmic immunofluorescence of carcinoma cells but it is of distinct granular pattern (Special Plate, Fig. 7 ) and can be recognized by its wide cross-reactivity and from the routine autoantibody testing.
Results
The total of 60 cases studied were selected only in so far as they had carcinomas of the colon resectable at operation as part of normal patient care. Most of the operations (44) were conducted personally by E.S.R.H., the remainder severally by surgical colleagues in hospitals in and around Melbourne. The patients (30 men, 30 women) were aged 28 to 89 years. All the tumours were adenocarcinomas without unusual histopathological features. They were graded clinicopathologically as (1) confined to colon, (2) extending only locally, and (3) disseminated.
Complete examination by all four tests was made in only 21 cases; the others had different combinations of tests (Table I) Repeat tests against frozen-stored tumour cells with stored serum gave the same results as originally, with only minor variations in intensity. When the stored cells were retested with fresh samples of autologous serum or lymphocytes obtained up to a year after the original tumour resection the results varied more in that serum reactions were occasionally reversed; there was remarkably consistent positive reactivity over a year by three separate lymphocyte samples from Case 1 (Table II) .
Lymphocytes from regional lymph nodes were not cytotoxic for autologous tumour cells in any of the four cases studiedone of these (Case 4) showed blood lymphocyte and serum cytotoxicity, one showed neither, and in the other two blood lymphocytes were not tested, though one (Case 13) was seropositive by immunofluorescence. Any lymphocytes carried over from the tumour tissue in the original cell suspension also appeared to have no cytotoxic effect.
There was nothing in the series to suggest any influence on the results obtained of age, sex, blood group, or anatomical site or histopathological appearance of the tumours. The latter included an assessment of lymphocytic infiltration of the carcinomas, though there is little prospect in this tumour of identifying it as an immunological response to viable tumour, necrotic tissue, or invading bowel organisms. There was no correlation between the immunological results and clinicopathological grading of the tumours except that of the six cases showing positive cytoplasmic immunofluorescence alone, three had obvious metastatic spread soon after operation. No beneficial effect on the immediate fate of the patient by any antitumour immunoreactivity (1, 2, 3, 4, 5, 6, 7, 8, 11, 12, 15, and 19) . The lymphocyte donors comprised four patients with malignant melanoma, three with squamous cell carcinoma, four with other carcinomas, one with a benign colonic polyp, and three normal subjects.
Sera from many subjects either normal or with carcinomas other than of the colon were employed as controls in cytotoxicity and immunofluorescence tests; none ever gave a positive result. No example of serum cytotoxicity was observed in the absence of active human complement. Study of the immunoglobulin class~l l in five sera (Cases 1, 3, 11, 13, and 19) giving positive membrane immunofluorescent staining or cytoplasmic staining or both showed this to be due predominantly to IgG, but two (Cases 13 and 19) also showed IgA activity; in another (Case 10) IgA appeared to predominate. No IgM antibody was detected.
Discussion
The results show that specific antitumour activity is common in patients with carcinoma of the colon. We estimate the true incidence of the phenomenon to be near 50%0. This assessment is based on the. incidence of lymphocytic or serum reactivity against tumour cell surface, which has more evident biological significance and has been entirely tumour-specific. Cytoplasmic immunofluorescence, which showed cross-reactivity in one serum (Case 19) against normal homologous colon mucosal cells, may well be only an epiphenomenon of tumour destruction in vivo (Nairn et al., 1971 ) and has been ignored in this calculation. One or more immunological reactions against tumour cell membrane occurred in 13 of the 60 cases studied, but only 21 were tested for all three membrane-reactive responses, 24 for lymphocytotoxicity, and 37 for serum cytotoxicity plus immunofluorescence. The figures almost certainly give a low estimate of overall immunoreactivity by the patients against their tumours because apart from unavoidable incomplete testing in the series various aspects of our test system favoured false-negative rather than false-positive results. In particular, a small lymphocyte to tumour cell ratio was employed in cytotoxicity tests and the extra antibiotics to prevent overgrowth of bowel organisms in culture could conceivably have restricted lymphocyte responsiveness; only unequivocal serum tests were reported positive.
Any lymphocytotoxicity was specific for colonic carcinoma, and cross-reactions between subjects were weaker than the autologous response. There was no cross-reactivity with other carcinomas or with normal colon whether homologous or autologous. Direct serum testing and absorption studies of complement-dependent cytotoxicity and membrane immunofluorescence also showed exclusive colonic carcinoma reactivity plus an irregular degree of individual specificity. Cytoplasmic immunofluorescence was restricted to colonic carcinomas except in Case 19, which also showed cross-reaction with homologous normal colon. Thus it seems established that the immunoreactivity is limited almost completely to colonic carcinoma while also having an individually specific component.
Lymphocytotoxicity was remarkably consistent in its crossreactions, and in repeat tests in Case 1 three different blood lymphocyte samples over a year showed no variation in activity. In contrast repeat sera sometimes showed reversal of the earlier response whether positive or negative-an original negative becoming positive may perhaps be explained by some form of antibody "release" after operative resection of antigenic tumour mass; the reverse process is presumably the more usual antibody subsidence after extirpation of antigenic stimulus and deserves further study as a possible favourable postoperative finding. The inconsistent cross-reactivity by sera in immunofluorescence tests with homologous colonic carcinomas is hard to explain. Possible fickle results in a delicate technical procedure could be responsible for only occasional anomalies and we are driven to conclude that the antibodies detected are directed against multiple antigens. No doubt a proportion of these are tumour-specific but some are probably shared with non-colonic carcinoma tissues. Presumably the carcinoma cells express different antigenicities from time to time and the antibody response will be correspondingly variable and not necessarily reactive against any current tumour cell population. Thus an antibody provoked by a tumour antigen eventually lost from the host may react against homologous but not autologous tumour.
As in the case of local lymphocyte reactivity in squamous cell carcinoma of the skin (Nairn et Active specific immunotherapy for colonic carcinoma cannot be contemplated with crude vaccines of autologous material from so contaminated a site and it may be fortunate that the tumour stimulates partial cross-reactivity with homologous colonic carcinomas. Highly purified carcinoembryonic antigens may be effective in this regard, perhaps most usefully to stimulate artificially cultivated autologous lymphocytes for therapeutic reinjection into the patient after optimum radical extirpation of tumour mass by conventional methods. showed no specific reactivity to colonic carcinoma.
